PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsUmbilical stem cells could treat cloudy cornea

BioNews

Umbilical stem cells could treat cloudy cornea

Published 11 December 2009 posted in News and appears in BioNews 538

Author

Marianne Kennedy

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).

New research offers promise of restoring vision in patients with congenital or acquired corneal scarring. The findings were presented at the 49th Annual Meeting of the American Society of Cell Biology in San Diego, US....


New research offers promise of restoring vision in patients with congenital or acquired corneal scarring. The findings were presented at the 49th Annual Meeting of the American Society of Cell Biology in San Diego, US.


The cornea is a transparent part of the front of the eye important for focusing light and protecting underlying structures. Disease or injury can cause scarring, impairing vision. Professor Winston Whei-Yang Kao and members of his team at the University of Cincinnati's ophthalmology department transplanted stem cells derived from the human umbilical cord into the corneas of mice with cloudy, thin corneas. The mice had been bred to lack a protein, lumican, which is important for transparency the cornea. Mice lacking lumican mimic the human condition.


Following transplantation, the corneas of the treated mice significantly improved their transparency. Furthermore, the transplanted cells were still present after three months and appeared to have assumed the properties of normal corneal cells called keratocytes. 'Our results suggest a potential treatment regimen for congenital and/or acquired corneal diseases. These stem cells are easy to isolate and can be recovered quickly from storage when treating patients' Professor Kao said. He added that the availability of human umbilical cord blood stem cells is almost unlimited. 'These findings have the potential to create new and better treatments - and an improved quality of life-for patients with vision loss due to corneal injury,' he said.


Currently only corneal transplantation is able to restore eyesight lost due to corneal scarring. However, Professor Kao explained that 'the number of donated corneas suitable for transplantation is decreasing as the number of individuals receiving refractive surgeries, like LASIK, increases'. He added: 'Worldwide, there is a shortage of suitable corneas for transplantation, and at the present time, there is no effective alternative procedure besides corneal transplantation to treat corneal blindness. There is a large need to develop alternative treatment regimens, one of which may be the transplantation of mesenchymal stem cells'.


Dr Francisco Arnalich, a researcher from Moorfields Eye Hospital in London who has carried out similar work in rabbits, explains: 'There is still a long way to go from saying that they achieved clear corneas - moreover they just state that they improved transparency, not that they reach normal transparency - to say that this could be a substitute of corneal grafting'.

Related Articles

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
25 October 2012 • 2 minutes read

Mouse retina grown from stem cells

by Dr Rachael Panizzo

Embryonic stem cells have been used to generate a basic retina, the part of the eye that detects light and is needed for vision. The retinal tissue could be used to treat some forms of blindness, such as retinitis pigmentosa and age-related macular degeneration, and to investigate and screen potential new drugs for a range of eye diseases....

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
22 October 2012 • 2 minutes read

Stem cell research may help treat common blindness

by Dr Sophie Pryor

US scientists have taken an important step towards using stem cells to treat age-related macular degeneration (AMD), the leading cause of blindness in the UK. The study demonstrates, for the first time, the ability to direct human iPS (induced pluripotent stem) cells to become...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
17 October 2012 • 1 minute read

Stem cell therapy used to treat glaucoma in rats

by Dr Lux Fatimathas

UK scientists have shown stem cells can be used to successfully stop glaucoma, an eye disorder, in rats. Stem cells were isolated from bone marrow and successfully grafted onto damaged nerves in the eye...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
24 September 2010 • 1 minute read

Stem cell study offers hope for hereditary blindness condition

by Dr Rachael Panizzo

Researchers have successfully transplanted retinal cone cells into blind mice, making progress towards a stem cell treatment for a form of blindness that causes degeneration of the eye's retina...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 August 2010 • 2 minutes read

Cause of corneal disease lies in the genes

by Sarah Pritchard

Researchers have discovered that people who carry a mutated form of the transcription factor 4 gene (TCF4) have as much as a 30-fold increased risk of developing Fuchs's corneal dystrophy...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
9 June 2009 • 2 minutes read

New stem cell treatment offers potential cure for blindness

by Dr Nadeem Shaikh

Three people suffering from blindness in one eye have been given a new medical treatment to radically improve their eyesight by a team working at the Australian University of New South Wales. According to the journal Transplantation, the method involves taking 'limbal' stem cells from the patient's...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
9 June 2009 • 1 minute read

Adult stem cells restore sight

by BioNews

A hospital in the UK is pioneering the use of stem cells to restore the eyesight of patients. Queen Victoria Hospital, in East Grinstead, West Sussex, says that it has helped more than 20 patients to see again over the past five years. Adult stem cells, taken either from the...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Chromosome-shaped genetics lab plans unveiled

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856